Amid increasing concerns from U.S. federal, state, and local agencies regarding the detection of Highly Pathogenic Avian Influenza (HPAI) A (H5N1) in dairy cows, Integrated DNA Technologies has unveiled the Avian Influenza Type A (H5) Primers and Probe Set. This new offering allows researchers to detect, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across various samples including birds, environment, dairy cows, and poultry farms.
Available for online ordering through IDT’s Tech Access Program, the Avian Influenza A (H5) Primers and Probe Set is manufactured in a certified, template-free environment. It includes an internal control to confirm false negatives, with an option to purchase an Avian Influenza Positive Sample Control. Demaris Mills, President of Integrated DNA Technologies, stated, “IDT is proud to leverage its track record in viral surveillance and response to be a trusted partner for researchers looking to understand, monitor, and control the spread of Avian flu.”
The Primers and Probe Set is compatible with IDT’s PrimeTime™ 1-Step 4X Broad-Range qPCR Master Mix, designed for inhibitor resistance and high performance. This master mix allows direct amplification of crude samples, saving time and costs associated with sample extractions from viral transport media (VTM), thus optimizing data confidence.
IDT has a history of supporting infectious disease and viral surveillance efforts. It has previously launched next-generation sequencing (NGS) solutions tailored for respiratory viruses and complete NGS library preparation solutions. The company has also been instrumental in supplying critical reagents during the COVID-19 pandemic.
To order the Avian Influenza Type A (H5) Primers and Probe Set, For additional product information and the Avian Influenza Type A (H5) Primers and Probe Set protocol, visit the same link.
For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has empowered genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, featuring the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases.
Seeking to fulfill its mission of accelerating the pace of genomics, IDT acquired Archer™ NGS Research Assays in December 2022. When combined with its existing solutions, the expanded portfolio helps realize the shared vision of enabling researchers to rapidly move from the lab to life-changing advances.
